James Aquavella, MD
Cornea and External Diseases Specialist Physician in Rochester, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 294 in Cornea and External Diseases Specialist Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
James Aquavella, MD reported a CMS MIPS final score of 99.9/100 - above the 83.1 national average - and filed 300 Medicare Part D claims in 2023.
- 99.9/100
- MIPS score · +17 vs avg
- 300
- Part D claims, 2023
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
James Aquavella, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 9% higher than 91% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where James Aquavella, MD sits
This provider among cornea and external diseases specialist physician peers
Across the 165 cornea and external diseases specialist physician providers who report both Medicare Part D prescribing and a MIPS quality score, James Aquavella, MD writes more Part D claims than 11% of them and scores higher on MIPS quality than 85% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one cornea and external diseases specialist physician peer from a representative sample of 60; the gold marker is James Aquavella, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
James Aquavella, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about James Aquavella, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Cornea and External Diseases Specialist Physician compares to other specialties among New York providers
Cornea and External Diseases Specialist Physician ranks #324 among New York's specialties (0% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Cornea and External Diseases Specialist Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
James Aquavella, MD's 2023 MIPS final score plotted against the Cornea and External Diseases Specialist Physician national average
- MIPS Final Score
- 99.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cornea and External Diseases Specialist Physician) - 99.9/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Cornea and External Diseases Specialist Physician US NPIs
99.9/100 MIPS final score - 16.8 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cornea and External Diseases Specialist Physician. Quality dim: 81.9. Cost dim: 100.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
James Aquavella, MD appears in the CMS NPPES registry as a Cornea and External Diseases Specialist Physician provider holding MD credentials at 601 ELMWOOD AVE BOX 659, Rochester, NY, 14642, with a listed phone of (585) 273-3937. NPI 1619912847 was issued on 06/19/2006.
Medicare Part D records for calendar year 2023 show 300 prescription claims written by this provider, covering 54 Medicare beneficiaries and totaling roughly $36K in drug spend, split 61% brand-name and 39% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.9/100 for the 2023 performance year (Quality 81.9, Cost 100), compared with the national average of 83.1.
Cornea and External Diseases Specialist Physician is a narrow specialty nationwide, with 294 enrolled providers across 43 states and an average of 1,232 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1619912847 |
|---|---|
| Specialty | Cornea and External Diseases Specialist Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/19/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm James Aquavella, MD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1619912847 is the unique 10-digit identifier CMS uses to link Aquavella across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where James Aquavella, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to James Aquavella, MD. To verify James Aquavella, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
61% brand-name claims vs 39% generic, on 300 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 497
- Total Day Supply
- 13,823
- Brand vs Generic
- 61% brand / 39% generic
- Brand Drug Cost
- $31K
- Generic Drug Cost
- $5K
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.23
- Gender Split
- 72% female / 28% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What James Aquavella, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
94 claims
- Latanoprost 36
Latanoprost
36 claims
- Polymyxin B Sul-Tr… 33
Polymyxin B Sul-Trimethoprim
33 claims
- Fluorometholone 30
Fluorometholone
30 claims
- Xiidra 19
Xiidra
19 claims
- Vancomycin Hcl 13
Vancomycin Hcl
13 claims
- Brimonidine Tartrate 12
Brimonidine Tartrate
12 claims
- Epinastine Hcl 11
Epinastine Hcl
11 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 94 |
| Latanoprost | 36 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 33 |
| Fluorometholone | 30 |
| Xiidra Lifitegrast | 19 |
| Vancomycin Hcl | 13 |
| Brimonidine Tartrate | 12 |
| Epinastine Hcl | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cornea and External Diseases Specialist Physician Overview
How James Aquavella, MD fits within the Cornea and External Diseases Specialist Physician landscape nationally.
James Aquavella, MD's 300 claims are below the specialty average of 1,232.
Nearby Cornea and External Diseases Specialist Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Aquavella.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cornea and External Diseases Specialist Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is James Aquavella, MD's specialty? ▼
How much does James Aquavella, MD prescribe under Medicare Part D? ▼
What is James Aquavella, MD's Medicare quality score? ▼
Where is James Aquavella, MD located? ▼
What is James Aquavella, MD's NPI number? ▼
Does James Aquavella, MD prescribe more brand-name or generic drugs? ▼
How many Cornea and External Diseases Specialist Physician providers are there in the US? ▼
What drugs does James Aquavella, MD prescribe most often? ▼
Does James Aquavella, MD accept Medicare? ▼
How can I verify James Aquavella, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology